The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort
Abstract
BACKGROUND: A main challenge for targeting chronic kidney disease (CKD) is the heterogeneity of its causes, co-morbidities and outcomes. Patients under nephrological care represent an important reference population, but knowledge about their characteristics is limited. METHODS: We enrolled 5217 carefully phenotyped patients with moderate CKD [estimated glomerular filtration rate (eGFR) 30-60 mL/min per 1.73 m(2) or overt proteinuria at higher eGFR] under routine care of nephrologists into the German Chronic Kidney Disease (GCKD) study, thereby establishing the currently worldwide largest CKD cohort. RESULTS: The cohort has 60% men, a mean age (±SD) of 60 ± 12 years, a mean eGFR of 47 ± 17 mL/min per 1.73 m(2) and a median (IQR) urinary albumin/creatinine ratio of 51 (9-392) mg/g. Assessment of causes of CKD revealed a high degree of uncertainty, with the leading cause unknown in 20% and frequent suspicion of multifactorial pathogenesis. Thirty-five per cent of patients had diabetes, but only 15% were considered to have diabetic nephropathy. Cardiovascular disease prevalence was high (32%, excluding hypertension); prevalent risk factors included smoking (59% current or former smokers) and obesity (43% with BMI >30). Despite widespread use of anti-hypertensive medication, only 52% of the cohort had an office blood pressure <140/90 mmHg. Family histories for cardiovascular events (39%) and renal disease (28%) suggest familial aggregation. CONCLUSIONS: Patients with moderate CKD under specialist care have a high disease burden. Improved diagnostic accuracy, rigorous management of risk factors and unravelling of the genetic predisposition may represent strategies for improving prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60674-5 · Cited by 4,200 · cited 2×
“The reduction in glomerular filtration rate (GFR) and the level of albuminuria and proteinuria are associated with poor prognosis, but otherwise relatively little is yet known about determinants of the course of CKD [3, 6, 7].”
BackgroundEstimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102 · cited 1×
“and cystatin C based Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) formulas [25, 26].”
BackgroundLevey, A. S., de Jong, P. E., Coresh, J., El Nahas, M., Astor, B. C., Matsushita, K., Gansevoort, R. T., Kasiske, B. L., & Eckardt, K.-U. (2011) · Kidney International · doi:10.1038/ki.2010.483 · Cited by 2,345
Self-citationChronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213 · cited 1×
“particular, CKD has been recognized as a major cardiovascular risk factor [4].”
BackgroundLevey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Cardiovascular and noncardiovascular mortality among patients starting dialysis
de Jager, D. J. (2009) · JAMA · doi:10.1001/jama.2009.1488 · Cited by 755
Lash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619 · cited 4×
“This is consistent with other CKD cohort studies [12, 13, 15–18] and suggests a potential for improvement, but also illustrates the difficulties of blood pressure control in CKD.”
BackgroundMethodResultInfluentialBlood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study
Kovesdy, C. P., Bleyer, A. J., Molnar, M. Z., Ma, J. Z., Sim, J. J., Cushman, W. C., Quarles, L. D., & Kalantar-Zadeh, K. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00004 · Cited by 213
Kuznik, A., Mardekian, J., & Tarasenko, L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-132 · Cited by 86 · cited 2×
“It is only slightly higher, however, than the 32% prevalence in individuals with CKD in the US National Health and Nutritional Examination Survey (NHANES) [33], suggesting that the proportion of diabetics in CKD populations with and without nephrological care in Europe and the USA is similar.”
Result
Cited by
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Self-citationThe cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386
Eckardt, K.-U., Alper, S. L., Antignac, C., Bleyer, A. J., Chauveau, D., Dahan, K., Deltas, C., Hosking, A., Kmoch, S., Rampoldi, L., et al. (2015) · Kidney International · doi:10.1038/ki.2015.28 · Cited by 371
Self-citationSkin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD
Schneider, M. P., Raff, U., Kopp, C., Scheppach, J. B., Toncar, S., Wanner, C., Schlieper, G., Saritas, T., Floege, J., Schmid, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060662 · Cited by 195
Self-citationBramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Seufert, J., Danne, T., & Holl, R. W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0837-x · Cited by 65
Metadata
- Authors
- Titze, S., Schmid, M., Kottgen, A., Busch, M., Floege, J., Wanner, C., Kronenberg, F., Eckardt, K.-U., for the GCKD study investigators, for the GCKD study investigators, Eckardt, K.-U., Titze, S., Prokosch, H.-U., Barthlein, B., Beck, A., Ganslandt, T., Gefeller, O., Schmid, M., Koster, J., Malzer, M., Schlieper, G., Eitner, F., Meisen, S., Kehl, K., Arweiler, E., Floege, J., Schaeffner, E., Baid-Agrawal, S., Schindler, R., Titze, S., Hubner, S., Dienemann, T., Hilgers, K. F., Eckardt, K.-U., Kottgen, A., Schultheiss, U., Walz, G., Kielstein, J. T., Lorenzen, J., Haller, H., Sommerer, C., Zeier, M., Busch, M., Paul, K., Wolf, G., Hilge, R., Sitter, T., Krane, V., Schmiedeke, D., Toncar, S., Wanner, C., Ekici, A. B., Reis, A., Forer, L., Schonherr, S., Weissensteiner, H., Kollertits, B., Raschenberger, J., Kronenberg, F., Gronwald, W., Zacharias, H., & Oefner, P.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09-30
- Volume
- 30
- Issue
- 3
- Pages
- 441-451
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2105017977
- Cited by
- 205
- References
- 11
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.